Zdrowie i gospodarka · 04/06/1997

FDA Revises Regulation for Cranial Electrotherapy Stimulators, Considering Potential Reclassification

The FDA is revoking a requirement for premarket approval of cranial electrotherapy stimulators, allowing for potential reclassification from class III to class II or class I, and is also requiring manufacturers to submit safety and effectiveness information.